KING OF PRUSSIA, PA, Aug. 1 /CNW/ - MDS Pharma Services, a leading
provider of innovative drug discovery and development solutions, announced
today the expansion of its Development & Regulatory Services (DRS) business in
Europe. MDS Pharma Services will now offer full-service DRS consulting
services to support development of new drugs and biopharmaceutical products
for clients in Europe.
The MDS Pharma Services' European DRS organization will also be fully
integrated with consultants in the United States and Canada to provide product
development consulting, program management, and regulatory affairs services
for new drugs and biopharmaceutical products.
"This expansion in Europe will greatly broaden our consulting
capabilities in development and regulatory services," said MDS Pharma Services
President David Spaight. "We will now be able to provide expertise to support
our biotechnology and Asian pharmaceutical clients in the process of
commercializing their products in North American and European markets."
This European expansion is being supported by the appointments of two
industry experts, Dr. Didier Saur, MD as Vice-President of Medical Affairs,
and Dr. Sarah Roberts, Ph.D. as Senior Director of Regulatory Affairs.
Based near Paris in Sèvres, France, Dr. Saur will lead the MDS Pharma
Services product development consulting, program management, and regulatory
affairs services for drugs and biopharmaceutical products in Europe. He will
also be responsible for organizing and chairing the Medical Advisory Board for
DRS. Dr. Saur has more than 20 years experience as a physician in the
pharmaceutical and contract research industry. Trained in internal and
intensive care medicine, clinical pharmacology and statistics, he is a
specialist in cardiovascular and metabolic disorders such as diabetes and
Based in Winnersh, near London, Dr. Roberts will provide expert
regulatory affairs consulting for clients on European regulatory issues. An
oncology research specialist with more than 10 years experience, Dr. Roberts
has worked with the Dana Farber Cancer Institute in Boston, Massachusetts and
the Gray Cancer Institute in London, England. She has considerable experience
with regulatory agencies in both North America and Europe, and most recently
served as a Director for Smart Regulatory Solutions Ltd, an independent
consulting firm she established.
About MDS Pharma Services
MDS Pharma Services offers a full spectrum of resources to meet the drug
discovery and development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around the world,
we apply advanced scientific and technological expertise throughout the drug
discovery and development process - from lead optimization, pre-IND research,
early clinical research (bioequivalence, phases I-IIa) and bioanalysis through
to global clinical development (phases IIb-IV), central lab and centralized
cardiac services. For more information, visit our website at www.mdsps.com.
MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ),
a global life sciences company that provides market-leading products and
services our customers need for the development of drugs and diagnosis and
treatment of disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging, radiotherapeutics,
and analytical instruments. MDS has more than 6,200 highly skilled people in
28 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24
hours a day.
For further information:
For further information: For Investors, Sharon Mathers, (416) 675-6777
ext. 34721, firstname.lastname@example.org; For Media, Charlene McGrady, (610)
239-7900 ext. 231, email@example.com